"10.1371_journal.pone.0020412","plos one","2011-06-03T00:00:00Z","Sharareh Siamakpour-Reihani; Joseph Caster; Desh Bandhu Nepal; Andrew Courtwright; Eleanor Hilliard; Jerry Usary; David Ketelsen; David Darr; Xiang Jun Shen; Cam Patterson; Nancy Klauber-DeMore","Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America","Conceived and designed the experiments: NK-D SS-R. Performed the experiments: SS-R JC DBN AC EH DK XJS JU. Analyzed the data: SS-R DBN AC EH DD XJS CP NK-D. Wrote the paper: SS-R JC CP NK-D.","Discovery of Novel Targets for Angiogenesis Inhibition, Provisional patent application no. 61/053,397. Inventors: Nancy Klauber-DeMore, MD, Cam Patterson, MD, PhD., Rajendra Bhati, MD filed 05/15/2008. Dr. Klauber-DeMore is co-founder and Chief Scientific Officer of Enci Therapeutics, Inc. Dr. Patterson is co-founder and Chief Executive Officer of Enci Therapeutics, Inc. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. Enci Therapeutics had no role in funding this study and none of the authors has received a salary from the company.","2011","06","Sharareh Siamakpour-Reihani","SSR",11,TRUE,2,8,8,4,TRUE,TRUE,TRUE,1,"11",TRUE
